We then verified the activity of the polymorphic regulatory region containing the 7p14.3 variant with an in vitro luciferase assay in two model systems, AR-negative (PC-3) and AR-positive (LNCaP) prostate cancer cells (Fig. 2a). Here, AR is linked to prostate cancer.